Black Diamond Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
HATZIS-SCHOCH BRENT officer: See Remarks
 Stock Option (Right to Buy) 11,578 $7.03 $81,393
Option
HATZIS-SCHOCH BRENT officer: See Remarks
 Stock Option (Right to Buy) 11,578 $7.03 $81,393
Sale
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 11,578 $32.49 $376,204
Option
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 11,578 $7.03 $81,393
Option
LEGGETT THOMAS officer: Chief Financial Officer
 Common Stock 3,000 $10.86 $32,580
Option
LEGGETT THOMAS officer: Chief Financial Officer
 Stock Option (Right to Buy) 3,000 $10.86 $32,580
Sale
LEGGETT THOMAS officer: Chief Financial Officer
 Common Stock 3,000 $10.86 $32,580
Sale
EPSTEIN DAVID M. director, officer: See Remarks
 Common Stock 12,000 $15.9 $190,788
Sale
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Common Stock 2,500 $15.66 $39,138
Option
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Stock Option (Right to Buy) 2,500 $10.86 $27,150
Sale
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Common Stock 2,500 $31.54 $78,858
Option
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Common Stock 2,500 $10.86 $27,150
Sale
EPSTEIN DAVID M. director, officer: See Remarks
 Common Stock 12,000 $31.39 $376,728
Option
EPSTEIN DAVID M. director, officer: See Remarks
 Common Stock 3,000 $6.42 $19,260
Option
EPSTEIN DAVID M. director, officer: See Remarks
 Stock Option (Right to Buy) 3,000 $6.42 $19,260
Option
HATZIS-SCHOCH BRENT officer: See Remarks
 Stock Option (Right to Buy) 5,400 $3.2 $17,280
Option
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 5,400 $3.2 $17,280
Option
EPSTEIN DAVID M. director, officer: See Remarks
 Stock Option (Right to Buy) 2,500 $6.42 $16,050
Option
EPSTEIN DAVID M. director, officer: See Remarks
 Common Stock 2,500 $6.42 $16,050
Option
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Common Stock 3,200 $10.86 $34,752
Option
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Stock Option (Right to Buy) 3,200 $10.86 $34,752
Option
HATZIS-SCHOCH BRENT officer: See Remarks
 Stock Option (Right to Buy) 4,078 $3.2 $13,050
Sale
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 4,078 $3.2 $13,050
Option
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 4,078 $3.2 $13,050
Option
LEGGETT THOMAS officer: Chief Financial Officer
 Stock Option (Right to Buy) 3,000 $10.86 $32,580
Sale
LEGGETT THOMAS officer: Chief Financial Officer
 Common Stock 3,000 $33.66 $100,983
Option
LEGGETT THOMAS officer: Chief Financial Officer
 Common Stock 3,000 $10.86 $32,580
Sale
LEGGETT THOMAS officer: Chief Financial Officer
 Common Stock 3,000 $33.66 $100,983
Option
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Stock Option (Right to Buy) 2,500 $10.86 $27,150
Sale
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Common Stock 2,500 $10.86 $27,150
Option
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Common Stock 2,500 $10.86 $27,150
Option
EPSTEIN DAVID M. director, officer: See Remarks
 Stock Option (Right to Buy) 3,000 $6.42 $19,260
Sale
EPSTEIN DAVID M. director, officer: See Remarks
 Common Stock 12,000 $33.04 $396,528
Option
EPSTEIN DAVID M. director, officer: See Remarks
 Common Stock 3,000 $6.42 $19,260
Sale
EPSTEIN DAVID M. director, officer: See Remarks
 Common Stock 12,000 $16.32 $195,852
Sale
VERSANT VENTURE CAPITAL VI, L.P. 10 percent owner
 Common Stock 10,393 $33.65 $349,693
Sale
BOLZON BRADLEY J PHD director, 10 percent owner
 Common Stock 10,393 $33.65 $349,693
Sale
BOLZON BRADLEY J PHD director, 10 percent owner
 Common Stock 130,017 $33.01 $4,291,861
Sale
VERSANT VENTURE CAPITAL VI, L.P. 10 percent owner
 Common Stock 130,017 $33.01 $4,291,861
Sale
BOLZON BRADLEY J PHD director, 10 percent owner
 Common Stock 536 $33.09 $17,738
Sale
VERSANT VENTURE CAPITAL VI, L.P. 10 percent owner
 Common Stock 536 $33.09 $17,738
Sale
BOLZON BRADLEY J PHD director, 10 percent owner
 Common Stock 4,194 $33.05 $138,612
Sale
VERSANT VENTURE CAPITAL VI, L.P. 10 percent owner
 Common Stock 4,194 $33.05 $138,612
Sale
BOLZON BRADLEY J PHD director, 10 percent owner
 Common Stock 200 $33.01 $6,603
Sale
VERSANT VENTURE CAPITAL VI, L.P. 10 percent owner
 Common Stock 200 $33.01 $6,603
Sale
BOLZON BRADLEY J PHD director, 10 percent owner
 Common Stock 4,500 $33.92 $152,654
Sale
VERSANT VENTURE CAPITAL VI, L.P. 10 percent owner
 Common Stock 4,500 $33.92 $152,654
Sale
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 4,078 $34.24 $139,618
Sale
BOLZON BRADLEY J PHD director, 10 percent owner
 Common Stock 15,598 $34.34 $535,635
Sale
VERSANT VENTURE CAPITAL VI, L.P. 10 percent owner
 Common Stock 15,598 $34.34 $535,635

Showing 50 to 100 of 190 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: